A detailed history of Exodus Point Capital Management, LP transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 68,264 shares of TSHA stock, worth $140,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,264
Holding current value
$140,623
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.01 - $2.46 $137,210 - $167,929
68,264 New
68,264 $137,000
Q1 2024

May 14, 2024

BUY
$1.43 - $3.25 $160,270 - $364,250
112,077 New
112,077 $322,000
Q4 2020

Feb 16, 2021

SELL
$19.14 - $28.13 $249,107 - $366,111
-13,015 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$22.4 - $24.47 $291,536 - $318,477
13,015 New
13,015 $292,000

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $99.6M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.